Generation of Two Induced Pluripotent Stem Cell (iPSC) Lines (BBANTWi006-A, BBANTWi007-A) from Brugada Syndrome Patients Carrying an SCN5A Mutation
Overview
Affiliations
Brugada syndrome (BrS) is an inherited primary electrical disorder of the heart. 25% of BrS patients carry a mutation in the SCN5A gene, encoding the cardiac specific voltage-gated sodium channel Nav1.5. Here we report two iPSC lines (BBANTWi006-A, BBANTWi007-A) of a brother and a sister carrying an SCN5A mutation (c.4813 + 3_4813 + 6dupGGGT) causing BrS. iPSCs were generated from dermal fibroblasts and reprogrammed with the Cytotune®-iPS 2.0 Sendai Reprogramming Kit (Invitrogen). The generated iPSCs showed a normal karyotype, expressed pluripotency markers, were differentiated into cells of the three germ layers and carried the original genotype.
The Role of Human-Induced Pluripotent Stem Cells in Studying Cardiac Channelopathies.
Begovic M, Schneider L, Zhou X, Hamdani N, Akin I, El-Battrawy I Int J Mol Sci. 2024; 25(22).
PMID: 39596103 PMC: 11593457. DOI: 10.3390/ijms252212034.
Brugada Syndrome: More than a Monogenic Channelopathy.
Liantonio A, Bertini M, Mele A, Balla C, Dinoi G, Selvatici R Biomedicines. 2023; 11(8).
PMID: 37626795 PMC: 10452102. DOI: 10.3390/biomedicines11082297.
IPSC reprogramming of two patients with spondyloepiphyseal dysplasia congenita (SEDC).
De Kinderen P, Rabaut L, Perik M, Peeters S, Ponsaerts P, Loeys B Stem Cell Res. 2023; 69:103080.
PMID: 36966641 PMC: 10240565. DOI: 10.1016/j.scr.2023.103080.